Not applicableStudy completedNCT03572036
What this trial is testing
Phosphodiesterase Type-5 Inhibitor Therapy in Sickle Cell People With Pulmonary Hypertension
Who this might be right for
Pulmonary HypertensionSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 38